Illinois Municipal Retirement Fund Lowers Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Illinois Municipal Retirement Fund reduced its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 70.7% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 26,299 shares of the medical instruments supplier’s stock after selling 63,507 shares during the period. Illinois Municipal Retirement Fund’s holdings in DENTSPLY SIRONA were worth $936,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of XRAY. CWM LLC boosted its position in shares of DENTSPLY SIRONA by 85.5% during the third quarter. CWM LLC now owns 4,379 shares of the medical instruments supplier’s stock worth $150,000 after buying an additional 2,018 shares during the period. SG Americas Securities LLC boosted its position in shares of DENTSPLY SIRONA by 45.3% during the third quarter. SG Americas Securities LLC now owns 28,389 shares of the medical instruments supplier’s stock worth $970,000 after buying an additional 8,854 shares during the period. Exchange Traded Concepts LLC boosted its position in shares of DENTSPLY SIRONA by 41.2% during the third quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier’s stock worth $51,000 after buying an additional 439 shares during the period. Czech National Bank boosted its position in shares of DENTSPLY SIRONA by 47.1% during the third quarter. Czech National Bank now owns 37,003 shares of the medical instruments supplier’s stock worth $1,264,000 after buying an additional 11,849 shares during the period. Finally, Asset Management One Co. Ltd. raised its stake in shares of DENTSPLY SIRONA by 5.0% in the third quarter. Asset Management One Co. Ltd. now owns 89,835 shares of the medical instruments supplier’s stock valued at $3,069,000 after acquiring an additional 4,294 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Up 0.7 %

DENTSPLY SIRONA stock opened at $30.57 on Monday. DENTSPLY SIRONA Inc. has a 1-year low of $26.27 and a 1-year high of $43.24. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95. The stock has a market cap of $6.34 billion, a PE ratio of -49.31, a P/E/G ratio of 1.24 and a beta of 0.98. The stock’s fifty day moving average is $32.53 and its two-hundred day moving average is $32.78.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.01. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The business had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $972.61 million. During the same quarter in the previous year, the firm earned $0.46 earnings per share. The business’s revenue was up 3.0% compared to the same quarter last year. On average, sell-side analysts expect that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were given a dividend of $0.16 per share. The ex-dividend date was Wednesday, March 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.09%. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s payout ratio is -103.22%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on XRAY. Needham & Company LLC reiterated a “buy” rating and issued a $42.00 price objective on shares of DENTSPLY SIRONA in a research note on Thursday, February 29th. Piper Sandler increased their price objective on DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a “neutral” rating in a research note on Friday, January 12th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, January 19th. Barrington Research reiterated an “outperform” rating and issued a $41.00 price objective on shares of DENTSPLY SIRONA in a research note on Thursday, April 18th. Finally, Leerink Partnrs reiterated an “outperform” rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, DENTSPLY SIRONA has a consensus rating of “Moderate Buy” and an average target price of $39.50.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.